ArticleGut and liver2021

Prognostic Factors for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer Receiving Neoadjuvant FOLFIRINOX.

Young Hoon Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.